Form 4: AstraZeneca Executive Mani Sharma Sells Shares

AstraZeneca SVP and Group Controller Mani Sharma sold 11,893 ordinary shares of the company on May 20, 2026.

Summary

• Mani Sharma, SVP, Group Controller and Head of Global Finance Services, sold 11,893 ordinary shares of AstraZeneca PLC.
• The transaction occurred on May 20, 2026, at a price of $185.78 per share.
• The sale price was converted from GBP 139.35 using a conversion rate of 1.3332.
• Following the transaction, the reporting person retains beneficial ownership of 19,262.4659 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine disclosure of an executive's personal financial transaction.

Positives

• The reporting person maintains a significant remaining equity stake of 19,262.4659 shares.

Negatives

• The sale represents a reduction in the direct equity holdings of a senior financial executive.

Risks

• Insider selling can sometimes be perceived by the market as a lack of confidence in near-term stock performance, though it is often for personal financial planning.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that executive stock sales are common occurrences for portfolio diversification or tax planning and do not necessarily reflect a change in the company's fundamental business outlook.

Comparison to Industry Standards

• The sale of shares by a senior executive is a standard corporate governance event and is consistent with typical executive compensation and liquidity practices in the pharmaceutical industry.

Stakeholder Impact

• Minimal impact expected on shareholders as this is a standard insider transaction.

Key Dates

Keywords

AstraZeneca, AZN, Insider Trading, Form 4, Executive Stock Sale